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Abstract. Material requirements for biological and medical applications are rapidly shifting from 
being simply non-toxic or biocompatible towards biomimetic three-dimensional structures capable of 
supporting de novo engineered living tissues. Multi-parameter matrices allowing for the precise control 
of biochemical properties (e.g. biodegradation, adhesion ligands, soluble effectors etc.) independently 
from mechanical network parameters are crucial for successfully engineering artificial biological systems. 
The formation of such materials demands novel chemistry which should be both bio-orthogonal and 
spatially specific. In this presentation I highlight the recent progress of our lab in the development of 
orthogonal synthetic strategies for the formation [1–2] and functionalization [3–4] of biodegradable 
biohybrid hydrogels composed of covalently crosslinked four-arm poly(ethylene glycol) (starPEG) and 
various glycosaminoglycan (GAG) polysaccharides with peptide conjugates. These multicomponent 
hydrogels were utilized to create a new smart material approach for disease modeling [5] as well as protein 
and drug delivery applications [6–7].  
The combination of polymer materials with an orthogonal enzymatically degradable peptide 
concept was utilized to create a new bio-orthogonal approach for ex vivo tissue regeneration. 
Implementation of polymer-peptide conjugates as crosslinking points in the hydrogel polymer network 
allows “on demand” polymer degradation for the gentle release of the formed tissue from the supporting 
material, while simultaneously keeping its cellular and extracellular matrix organisation untouched. We 
showed the perspective of this technique by the creation of corneal endothelial lamella [8], which from 
one side is a very simple cell monolayer tissue, but from another is extremely challenging in the production 
because of its very fragile nature. Our proposed synthetic technique allows for the first time the formation 
of physiologically relevant size human cornea endothelial lamella tissue suitable for surgical implantation 
in descemet membrane endothelial keratoplasty (DMEK).  
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